biosimilar

FDA puts in efforts to help make development of biosimilar and interchangeable insulin products

Read more

Novartis’s Sandoz licenses proposed multiple sclerosis biosimilar

Read more

Dr Reddy’s launches Roche’s Avastin biosimilar in India

Read more

Mylan and Biocon launch first Trastuzumab Biosimilar, Ogivri, in Australia

Read more

Dr Reddy’s and TR-Pharm in agreement

Read more

Generic opportunities outweigh challenges emanating across emerging markets: ICRA

Read more

Intas launches RAZUMAB, the first biosimilar to Lucentis (ranibizumab)

Read more

Syngene seeks approval for IPO, files DRHP

Read more